People · Operator

ROBERT W. LOBBAN

Named in public records as an officer, director or promoter · active 2016–2016 · Other

1
Companies
1
Filings
$8.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Brook & Whittle Holding Corp.OtherSeries A$8.7M$76.6M2016
Operator network

ROBERT W. LOBBAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Michael W. Rubel · 10 companies · 1 sharedMichael W. RubelJames A. Parsons · 9 companies · 1 sharedJames A. ParsonsMichael J. Foster · 8 companies · 1 sharedMichael J. FosterMatthew A. Collins · 2 companies · 1 sharedMatthew A. CollinsANDREW C. SHARP · 1 companies · 1 sharedANDREW C. SHARPCARL A. FAZIO · 1 companies · 1 sharedCARL A. FAZIOJONATHAN C. COLLINS · 1 companies · 1 sharedJONATHAN C. COLLI…JONATHAN J. COLLINS · 1 companies · 1 sharedJONATHAN J. COLLI…PAUL E. ROUGHAN · 1 companies · 1 sharedPAUL E. ROUGHANSCOTT A. MURCHISON · 1 companies · 1 sharedSCOTT A. MURCHISONSIMON W. GORE-GRIMES · 1 companies · 1 sharedSIMON W. GORE-GRI…STEPHEN T. STEWART · 1 companies · 1 sharedSTEPHEN T. STEWARTZUBIN T. AVARI · 1 companies · 1 sharedZUBIN T. AVARIBrook & Whittle Holding Corp. · $8.7M raisedBrook & Whittle Holdi…ROBERT W. LOBBANRL
ROBERT W. LOBBAN Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside ROBERT W. LOBBAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Michael W. Rubel110
James A. Parsons19
Michael J. Foster18
Matthew A. Collins12
ZUBIN T. AVARI11
JONATHAN J. COLLINS11
STEPHEN T. STEWART11
SCOTT A. MURCHISON11
JONATHAN C. COLLINS11
CARL A. FAZIO11
PAUL E. ROUGHAN11
SIMON W. GORE-GRIMES11
ANDREW C. SHARP11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.